nach oben

The International Journal of Cardiovascular Imaging

Erschienen in:

01.12.2011 | Review

Clinical trial experience with transcatheter aortic valve insertion

verfasst von: Thomas J. Helton, Samir R. Kapadia, E. Murat Tuzcu

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Surgical aortic valve replacement has long been considered the standard of care for patients with severe symptomatic aortic stenosis, however, an aging population with increasing complex comorbidities now represents a growing population of patients that is often considered inoperable for a traditional surgical approach. Transcatheter aortic valve implantation is a developing technology that offers an alternative treatment modality for these very high risk patients. This manuscript will review the currently available clinical trial data with transcatheter aortic valve implantation and offer perspective as to the future of this novel technology.

Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Barwolf C, Boersma E, Ravaud P, Vahanian A (2005) Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26(24):2714–2720PubMedCrossRef

Pai RG, Kapoor N, Bansal RC, Varadarajan P (2006) Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 82(6):2116–2122PubMedCrossRef

Varadarajan P, Kapoor N, Bansal RC, Pai RG (2006) Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 82(6):2111–2115PubMedCrossRef

Bouma BJ, van Den Brink RB, van Der Meulen JH, Verheul HA, Cheriex EC, Hamer HP, Dekker E, Lie KI, Tijssen JG (1999) To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 82(2):143–148PubMed

Bach DS, Cimino N, Deeb GM (2007) Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 50(20):2018–2019PubMedCrossRef

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24):3006–3008PubMedCrossRef

Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB (2004) Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43(4):698–703PubMedCrossRef

Kapadia SR, Tuzcu EM (2009) Transcatheter aortic valve implantation. Curr Treat Options Cardiovasc Med 11(6):467–475PubMedCrossRef

Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA (2009) A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 53(20):1855–1858PubMedCrossRef

10.

Andersen HR, Knudsen LL, Hasenkam JM (1992) Transluminal implantation of artificial heart valves Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 13(5):704–708PubMed

11.

Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V (2006) Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47(6):1214–1223PubMedCrossRef

12.

Zajarias A, Cribier AG (2009) Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 53(20):1829–1836PubMedCrossRef

13.

Krishnaswamy A, Tuzcu EM, Kapadia SR (2010) Update on transcatheter aortic valve implantation. Curr Cardiol Rep 12(5):393–403PubMedCrossRef

14.

Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55(11):1080–1090PubMedCrossRef

15.

Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1):62–69PubMedCrossRef

16.

Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG (2006) Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114(6):591–596PubMedCrossRef

17.

Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C (2008) United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86(1):46–54; discussion 54–45

18.

Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G (2010) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J

19.

Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schachinger V, Mohr FW, Wimmer-Greinecker G (2010) One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg

20.

The heart.org (2008) Low 30-day and six-month mortality for transfemoral valve implantation in PARTNERS EU and SOURCE

21.

Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15):1616–1624PubMedCrossRef

22.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50(1):69–76PubMedCrossRef

23.

Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A (2009) Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv 2(9):828–833PubMedCrossRef

24.

Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, Ramondo A, Ussia GP, Ettori F, Poli A, Brambilla N, Saia F, De Marco F, Colombo A (2010) Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 3(4):359–366PubMedCrossRef

25.

JC. L Transcatheter aortic valve implantation with the CoreValve ReValving Device. In: Transcatheter cardiovascular therapeutics, Washington, 12th Oct 2008

26.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (17):1597–1607

27.

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement. http://www.clinicaltrials.gov/ct2/show/NCT01240902?term=Corevalve&rank=4. Accessed 1 March 2010

28.

Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG (2010) Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg 139 (5):1107–1113, 1113 e1101

29.

Leontyev S, Walther T, Borger MA, Lehmann S, Funkat AK, Rastan A, Kempfert J, Falk V, Mohr FW (2009) Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 87(5):1440–1445PubMedCrossRef

30.

Thomas M (2010) The global experience with percutaneous aortic valve replacement. JACC Cardiovasc Interv 3(11):1103–1109PubMedCrossRef

31.

Kolh P, Kerzmann A, Honore C, Comte L, Limet R (2007) Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg 31(4):600–606PubMedCrossRef

32.

Ussia GP, Mule M, Barbanti M, Cammalleri V, Scarabelli M, Imme S, Capodanno D, Ciriminna S, Tamburino C (2009) Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 30(14):1790–1796PubMedCrossRef

Titel: Clinical trial experience with transcatheter aortic valve insertion
verfasst von: Thomas J. Helton
Samir R. Kapadia
E. Murat Tuzcu
Publikationsdatum: 01.12.2011
Verlag: Springer Netherlands
Erschienen in: The International Journal of Cardiovascular Imaging / Ausgabe 8/2011
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-011-9825-2

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Clinical trial experience with transcatheter aortic valve insertion

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2011

Aortic root dimension changes during systole and diastole: evaluation with ECG-gated multidetector row computed tomography

Clinical trial experience with the MitraClip catheter based mitral valve repair system

Transcatheter treatment approaches for aortic valve disease

Vascular access in transcatheter aortic valve implantation

Transcatheter valve repair/implantation

Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie